Unmind logo

Mental Health ROI Compared to Other Health Conditions

The return depends on whether people come back

Content

  • Why the comparison is structural, rather than a scoreboard
  • The numbers Unmind can stand behind
  • The variable that actually decides the ROI conversation
  • What to ask before you compare programs

When a benefits budget is finite, every program has to compete for the same dollar. A CHRO weighing a mental health investment against a diabetes management program or a cardiovascular screening initiative is really asking one question: which of these returns the most value for what it costs.

The honest answer is that mental health ROI cannot be compared to other conditions on a like-for-like number, because the two run on different mechanics. A vaccination program or a screening initiative returns value the moment someone shows up. Coverage itself is close to the whole story. Mental health support only returns value if people actually use it, which means the real comparison a CHRO should be running is not "which condition has the bigger multiplier" but "which program in my stack is actually built to drive utilisation, and which one is just sitting there as a line item."

Why the comparison is structural, rather than a scoreboard

Most population health programs are one-time or low-frequency interventions. A screening catches a condition early. A vaccine confers protection in a single dose. The return on that spend is largely locked in once the intervention happens, regardless of what the employee does next.

Mental health support doesn't work that way. It's an ongoing relationship, rather than a single event, and the return depends entirely on whether people keep coming back. That's precisely where most employer mental health spend quietly fails today. The category norm for a traditional Employee Assistance Program sits under 2% engagement, and a legacy EAP running at 2 to 4% utilisation is providing legal cover rather than care. An EAP contract can look identical on paper to a well-utilised program and return almost nothing, because the entire value chain runs through a door that almost nobody opens.

This is the structural reason mental health investment cases get harder to build than a diabetes or cardiovascular program. The underlying value isn't smaller; the same benefit can just produce wildly different returns depending entirely on adoption. A CHRO comparing programs side by side has to ask a different question of the mental health line than of most other health lines: not "does this work in principle" but "is this actually being used."

The numbers Unmind can stand behind

Rather than borrow figures from categories we don't measure, here's what we can stand behind from our own record.

The published position from Unmind is a return of $4.6 for every $1 invested. That figure comes from ROI research Unmind ran itself, rather than a third-party or cross-category benchmark, and it's the number we ask CHROs to hold us to.

We also have a controlled, six-month study run across four countries with a global consumer goods employer, giving employees in Canada, Mexico, the Netherlands and India access to the Unmind platform. The results were a projected ROI of 3.49x, an estimated $1M in productivity impact, a 16% reduction in stress among high-stress employees, and a 10% reduction in work impairment (absenteeism plus presenteeism combined) for that same high-stress group. Those numbers held up in a live, cross-market rollout rather than a lab setting, which is what makes them a fair comparison point for a CHRO evaluating a real deployment rather than a pilot.

Both of those figures share a dependency that a screening or vaccination ROI simply doesn't have. They only hold if people engage with the platform. That's why utilisation sits at the center of the product model at Unmind, rather than as an afterthought measured once a year.

The variable that actually decides the ROI conversation

If mental health ROI depends on utilisation in a way other conditions don't, the CHRO's real diligence question shifts. It's not "what's the average return in this category," it's "what is this specific program doing to drive engagement, and can I see the data."

This is the gap that keeps legacy EAPs stuck in single digits. A service network that gets paid whether or not anyone calls has no built-in reason to solve for reach. At Unmind, the model is built the other way around, with Nova offering confidential, always-available support that routes people to Therapy & Coaching or a helpline when they need more, and Insights & Assessments giving HR and benefits teams a real-time read on engagement and stress signals across the workforce, rather than a single annual utilisation report. When a program is instrumented to show where support is landing and where it isn't, a CHRO can manage the ROI conversation as it happens rather than discover the utilisation problem at renewal.

What to ask before you compare programs

Before ranking mental health against any other condition in the benefits stack, a benefits leader needs three answers, rather than a borrowed multiplier:

  • What is this program's actual utilisation rate today, and how does it compare to the sub-2% category average for EAPs
  • Is there a measurable, published return tied to a real deployment, rather than a modeled or projected industry average
  • Can the vendor show engagement and outcome data on an ongoing basis, or only a single number at signing

Programs that can't answer the first two honestly are not comparable on ROI at all, whatever number sits in their sales deck.

For the full picture of the ROI research behind that number and how the 4.6x figure was calculated, see unmind.com/roi. And if the comparison you're actually running right now is mental health against your existing EAP rather than against another condition entirely, our broader cost-benefit breakdown of EAP and employee wellness initiatives walks through that comparison in detail.